Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsIndonesian Institute of Sciences (LIPI) researcher Hendri Maja Saputra said the device, dubbed the Gerlink LIPI High Flow Nasal Cannula – 01, was useful for treating patients in the early stages of COVID-19 who were still able to breathe independently.
Terawan said the method had shown empirical results supported by ongoing research. He claimed that DSA was already widely used by hospitals and that the implementation only needed a standard operational procedure (SOP) decided by the head of each hospital.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.